Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to ...

Stevens-Johnson syndrome and its more severe variant, toxic epidermal necrolysis, are rare and dangerous immunologic diseases ...

The aim of this trial is to investigate the ability of 64 Cu-SAR-bisPSMA PET/computed tomography (CT) to detect recurrence of prostate cancer, with evaluation across 2 imaging timepoints, Day 1 (day ...

An international team led by HZB chemist Michelle Browne conducted a rigorous investigation that demonstrated the potential ...

Tapping wind at sea to power green H2 production is an attractive concept but the options for putting it into practice all ...

Stellar Market Research reported that the Oxygenator Market is growing at a CAGR of 5.9 % over the period from 2025 to 2032. The Growing Geriatric Population is an important trend driving the growth ...

The World Health Organization (WHO) today posted an outbreak notice about a rise in COVID activity in three of its regions, ...

Researchers from the Göttingen Cluster of Excellence Multiscale Bioimaging (MBExC) have uncovered the 3D structure of the ...

Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of antibiotics against drug-resistant bacteria. The team, led by scientists at the ...

ZeroAvia says it will build a hydrogen-electric powertrain factory in Scotland to produce high-temperature proton exchange membrane (HTPEM) fuel cell systems, while Thyssenkrupp Nucera and Fraunhofer ...

In the EU, GOHIBIC (vilobelimab) has been granted marketing authorization under exceptional circumstances for the treatment of adult patients with SARS-CoV-2-induced acute respiratory distress ...

The global bullous keratopathy market is forecasted to grow at a compounded annual growth rate (CAGR) of 4.3% from 2023 to 2033, is anticipated, with an anticipated closing value of USD 650 Million by ...